Harnessing Europe’s untapped potential: small and medium pharma
EUCOPE asks the European Commission to put research at the heart of its Pharmaceutical Strategy
The European Commission’s Pharmaceutical Strategy for Europe must:
- Provide ambitious measures to foster research in rare diseases and other disease areas for which we currently have no cure.
- Harness the potential of small and medium pharmaceutical and medical technology companies.
- Ensure that there is a supportive legal and regulatory framework to nurture their growth.
Against the backdrop of the European Commission’s roadmap to a Pharmaceutical Strategy, EUCOPE is asking the Commission to leverage this opportunity to harness the potential of small and medium sized pharmaceutical and medical technology companies in tackling unmet needs.